Researchers show that an efficacious breast cancer drug can be reconstituted from one that is susceptible to resistance.

Published Date: 07 Feb 2024

Targeting a protein known as TACC3 (transforming acidic coiled-coil containing protein 3) has been demonstrated by researchers at MUSC Hollings Cancer Center to restore the effectiveness in a recent paper published in Cancer Research.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers find distinct cell receptors with the potential for new treatments.

2.

Breast cancer patients' arms swell less after an effective lymph node transfer.

3.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

4.

Too Many Chest CTs for Incidental Lung Nodules?

5.

Global warming could be driving up women's cancer risk, find researchers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot